COOL TREATMENTS
COOL TREATMENTS®
Premium protocols for aesthetic laser treatments with the Dermablate® COOL LASER®
Premium protocols for the Dermablate® COOL LASER® – Exclusive applications for aesthetic indications – Standardized protocols with clinical validation – Dual-step treatment concept for maximum efficacy – Strong clinical marketing concept – Recognizable brand structure for effective clinic marketing
JENA, Germany, August 4, 2025 – Asclepion Laser Technologies has been a leading company in the market for aesthetic laser medicine for over 45 years. Constant new developments make Asclepion an outstanding company in the optical industry. Following the successful launch of the Er:YAG laser Dermablate® in September 2021 at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco, the company is today introducing a new generation of treatment protocols for this laser system: the COOL TREATMENTS®. In 1995, Asclepion introduced the first Er:YAG laser, the MCL29 Dermablate, and is now setting new standards with the Dermablate® with its high power, integrated smoke evacuation and innovative handpieces.
COOL TREATMENTS®: A new era of standardized, exclusive laser protocols
Developed exclusively for the Dermablate® COOL LASER®, the COOL TREATMENTS® unleash the full potential of Erbium:YAG technology. These premium protocols are tailored for popular aesthetic indications such as non-invasive blepharoplasty, perioral resurfacing, and dual neck rejuvenation. All protocols deliver clinically proven results with minimal downtime – a clear advantage for both physicians and patients. COOL LASER® stands for cutting-edge Er:YAG technology, and the COOL TREATMENTS® are its most visible expression. Together, they form a strong duo, offering not only impressive clinical outcomes but also powerful support in patient communication and clinic marketing.
More than treatments: A clinical marketing concept
The COOL TREATMENTS® are more than just procedures – they are part of a comprehensive clinical marketing strategy by Asclepion. The aim is to increase visibility and differentiation of Dermablate® treatments on the aesthetic market.
Physicians receive a professional tool to position their practice – with clearly defined protocols, strong branding and supporting visuals. Patients benefit from transparent information, realistic expectations, and reproducible results.
Thanks to their clear structure, clinical validation, and high degree of standardization, the COOL TREATMENTS® are safe, reproducible, and adaptable to individual needs – creating a new level of trust and satisfaction.
Standardized, validated, flexible
All COOL TREATMENTS® are based on carefully calibrated parameters – including fluence, pulse duration and scanning techniques – to ensure maximum effectiveness with minimal downtime.
A wide range of handpieces (e.g. VarioSpot, MicroSpot EXPERT, COLD and HOT) allows for precise, indication-specific energy delivery. Dual-step protocols and, in some cases, the use of multiple laser sources enhance results and extend the scope of applications. Thanks to distinct names, consistent color codes, and easily recognizable icons, each treatment becomes a brand in itself – ideal for in-clinic marketing, digital communications, and patient education.
COOL TREATMENTS® at a glance
The new protocol series includes four standardized treatments, all designed to achieve maximum results with minimal effort:
- COOL BLEPH – The non-invasive laser treatment for upper and lower eyelids – visibly rejuvenating, no surgery required
- COOL ORA® – Precise perioral resurfacing for smooth, firm skin around the mouth
- COOL YELLOW® – Dual approach combining 577 nm yellow light and Er:YAG for vascular and pigment lesions
- COOL VIVE® – Dual neck lifting for tighter skin and more defined contours – without a scalpel
Tailored to modern patient needs
The COOL TREATMENTS® are designed for patients who seek effective and minimally invasive aesthetic procedures – without compromising on visible results. They are ideal for individuals with early signs of aging or defined target areas (e.g. eyelids, perioral region, neck), for those who prefer to avoid surgery but still want measurable outcomes, and for clinics that value standardized workflows and recognizable offerings. The modular structure allows for customized adaptation to skin type and treatment goals – ensuring maximum satisfaction on both sides.
Asclepion Laser Technologies has been a leading company in international medical laser technology since 1977. Asclepion owes its success to the continuous development of new technologies. This has made it an outstanding company in the optical industry. The award as TOP100 of the most innovative medium-sized companies in Germany is proof of this. Today, over 70 countries trust Asclepion’s “Made in Germany” technology and experience. Asclepion has achieved this outstanding position in the market because it has created a unique supply system that ensures the success of distributors and doctors. The leadership in service that Asclepion has built up over the years brings many positive effects – both for its customers, partners and patients.
30 years of Dermablate
Asclepion Laser Technologies celebrates a milestone in laser medicine – 8 generations over 30 years Powerful Er:YAG lasers – State-of-the-art technology for aesthetic medicine – Focus on skin rejuvenation and scar treatment – Clinical excellence and maximum reliability as a recipe for success
25. September 2025 – CCR LONDON
CCR London will take place on 25 & 26 September 2025, bringing together all sectors of the medical aesthetic community. The event is organised by Aesthetics, the brand behind ACE, the Aesthetics Awards…
14. April 2025 – DUBAI DERMA
The Dubai Derma has become the largest scientific dermatology congress in the Middle East, North Africa and the Indian subcontinent. The 24th edition will bring together dermatologists, industry leaders and key decision makers …